Medications for Opioid Use Disorder (MOUD) Study
The MOUD study examined patient outcomes from several opioid use disorder (OUD) treatments.
Highlights of CDC's work to prevent overdoses and substance use-related harms.
View fatal and nonfatal overdose data dashboards, and pharmacy dispensing rate maps.
Overdose which occurs with exposure to more than one drug, with or without the person's knowledge.
For Health Care Professionals
Overdose Prevention for Health Care Providers
Resources for health care providers on pain management, opioids, and opioid use disorder.
2022 CDC Clinical Practice Guideline at a Glance
Overview of the intended use for 2022 Clinical Practice Guideline for prescribing opioids for pain.
Clinician trainings on pain management, opioid use disorder, naloxone, and substance use disorders.
For Public Health Professionals
The hub for CDC's Overdose Data to Action program, including information and resources.
Learn about CDC's Drug-Free Communities program and access related resources.
What You Should Know About Xylazine
Xylazine is a non-opioid sedative or tranquilizer. Xylazine is not approved for use in people.
Resources for Public Health Professionals
Find overdose prevention and intervention resources for public health professionals.
Health Equity and Drug Overdose
CDC is committed to addressing health inequities and to ensuring health equity.
Overdose Resource Exchange (ORE)
Overdose Resource Exchange (ORE)
Public Health Considerations for Strategies and Partnerships
Information on overdose prevention strategies and partnerships for healthcare professionals.